AAF
SLXP

Andra AP-fonden’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Andra AP-fonden’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-13,000
Closed -$1.49M – 612
2014
Q4 		$1.49M Buy
+13,000
New +$1.57M 0.03% 503

Other funds holding SLXP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
YCMGA
York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Andra AP-fonden's SLXP Position: Q1 2015 in Review

Andra AP-fonden sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q1 2015, closing a stake of 13,000 shares — an estimated $1.49M sold.

Andra AP-fonden first reported a position in SLXP in Q4 2014 and held it in 1 quarter. The position peaked at $1.49M in Q4 2014. 298 funds tracked by Wall St. Rank hold SLXP as of Q1 2015.

  • Andra AP-fonden reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q1 2015 after selling out during the quarter.
  • Andra AP-fonden sold 13,000 SALIX PHARMACEUTICALS LTD DEL shares in Q1 2015, an estimated $1.49M.
  • Andra AP-fonden first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q4 2014 and held it in 1 quarter.
  • Andra AP-fonden's SALIX PHARMACEUTICALS LTD DEL position peaked at $1.49M in Q4 2014.
  • 298 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q1 2015.

Based on Andra AP-fonden's 13F filing for Q1 2015, filed 14 May 2015.